SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 2, 2026

GLUE

Monte Rosa Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $100K total
Actionable Insight • Neutral

Monitor for additional insider selling in the next 30 days — isolated small sales by executives are common and typically routine, but a pattern could signal concern. Also watch upcoming R&D updates or clinical trial data readouts that may influence sentiment.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
GLUE ▲ +7.96% at T+60d
NEUTRAL call +7.96% · α vs SPY -2.95% · entry $17.96 → $19.39
Entry = T+0 close
Mar 2, 2026
via day close
T+1d
+3.62%
call +3.62% · α +2.91%
$18.61
settled 8mo ago
T+5d
-3.79%
call -3.79% · α -3.32%
$17.28
settled 8mo ago
T+20d
-8.41%
call -8.41% · α -4.00%
$16.45
settled 7mo ago
T+60d
+7.96%
call +7.96% · α -2.95%
$19.39
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Monte Rosa Therapeutics CEO Markus Warmuth and Principal Accounting Officer Edmund Dunn sold shares in a recent cluster of transactions. Warmuth sold $98K in stock, while Dunn exercised options for over 25,000 shares and sold a small portion. The total open-market sales amount to less than 0.1% of the company's $1.2B market cap, indicating limited economic significance.

Key Financial Metrics

Direction
selling
Total Value
$100.5K
Insiders
2

Key Facts

  • CEO Markus Warmuth sold $97,974 worth of shares in an open-market transaction.
  • Principal Accounting Officer Edmund Dunn exercised options for 25,700 shares (total value $344,637) and sold 139 shares for $2,496.
  • All open-market sales totaled $100,471, representing less than 0.01% of the company's $1.2B market cap.
  • The transactions occurred over a 7-day window with no accompanying commentary or filings suggesting broader corporate changes.

Financial Impact

$100,471 in total open-market sales; option exercises represent non-cash events.

insider ownershipshare count (dilution from option exercise)

Risk Factors

  • Perception risk from CEO selling, even if minimal in value.
  • Dilution from recent option exercises, though economically small at current scale.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-GLUE-1772749697007
19 reports for GLUE
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 4 best @ T+60▲ +18.17%Apr 20, 2026
Filters
Rows
Reports for GLUE — sortable, filterable
TypeNow
Oct 1, 2026
26d ago
8-K
BULLISH ★ 7/10
$11.26awaiting T+60—$10.66 (−5.33%)
Sep 30, 2026
27d ago
Press Release
NEUTRAL ★ 5/10
$11.26awaiting T+60—$10.66 (−5.33%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$15.71awaiting T+60—$10.66 (−32.15%)
Jul 17, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.48 $9.89▼ −57.88%▼ −62.72%$10.66 (−54.60%)
Jul 7, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.06 $11.93▼ −50.42%▼ −52.73%$10.66 (−55.69%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.66 (−55.97%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.66 (−55.97%)
Jun 29, 2026
17w ago
144
NEUTRAL ★ 2/10
$24.20 $11.89▼ −50.87%▼ −54.43%$10.66 (−55.95%)
Jun 25, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.29 $12.60▼ −43.47%▼ −49.56%$10.66 (−52.18%)
Jun 2, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$17.59 $14.32▼ −18.59%▼ −21.09%$10.66 (−39.40%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026